In this study, to assess the anti-tumor efficacy of NK-derived exosomes that overexpress both NKG2D and IL24, the NK cells expressing NKG2D and IL24 were constructed and NK-Exos were extracted. The gene discussed is IL24; the disease is neoplasm.